Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kewaunee Scientific (KEQU) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to $2.5 million.

  • Kewaunee Scientific's Consolidated Net Income fell 1582.09% to $2.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $12.0 million, marking a year-over-year decrease of 3658.32%. This contributed to the annual value of $11.6 million for FY2025, which is 3921.92% down from last year.
  • According to the latest figures from Q4 2025, Kewaunee Scientific's Consolidated Net Income is $2.5 million, which was down 1582.09% from $3.2 million recorded in Q3 2025.
  • Over the past 5 years, Kewaunee Scientific's Consolidated Net Income peaked at $11.2 million during Q2 2024, and registered a low of -$3.1 million during Q4 2021.
  • In the last 5 years, Kewaunee Scientific's Consolidated Net Income had a median value of $1.2 million in 2023 and averaged $1.4 million.
  • In the last 5 years, Kewaunee Scientific's Consolidated Net Income plummeted by 176787.88% in 2021 and then skyrocketed by 258245.61% in 2023.
  • Quarter analysis of 5 years shows Kewaunee Scientific's Consolidated Net Income stood at -$3.1 million in 2021, then surged by 96.3% to -$114000.0 in 2022, then skyrocketed by 2582.46% to $2.8 million in 2023, then rose by 6.54% to $3.0 million in 2024, then decreased by 15.82% to $2.5 million in 2025.
  • Its Consolidated Net Income was $2.5 million in Q4 2025, compared to $3.2 million in Q3 2025 and $4.9 million in Q2 2025.